Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Xilong Scientific Co., Ltd. operates in the chemical sector, focusing on the production of fine chemicals and specialty chemicals primarily for the pharmaceutical and agricultural industries in China. The company's competitive position is bolstered by its established relationships with major domestic clients and a diversified product portfolio that includes agrochemicals and pharmaceutical intermediates.
Xilong generates revenue through the sale of specialty chemicals, leveraging its production capabilities to offer competitive pricing. The company benefits from economies of scale in its manufacturing processes, allowing it to maintain a cost advantage over smaller competitors. However, the low gross margin of 7.1% indicates pricing pressures in the industry.
Changes in raw material prices, particularly for petrochemicals
Regulatory changes affecting chemical production standards in China
Demand fluctuations in the agricultural sector, especially for pesticides and herbicides
Market share changes in the domestic chemical industry
Regulatory changes in chemical manufacturing that could increase compliance costs
Technological disruption from more efficient production methods or alternative materials
Increased competition from domestic and international chemical manufacturers
Potential price wars in the agrochemical segment
Negative net margin indicates potential liquidity issues if losses continue
Dependence on working capital management due to low free cash flow
moderate - The company's performance is linked to industrial activity and agricultural demand, which can be cyclical.
Interest rates affect financing costs for capital expenditures and may influence demand for agricultural products, impacting revenue.
minimal - The company has a moderate debt-to-equity ratio of 0.54, indicating limited reliance on credit markets.
value - Investors may seek undervalued opportunities given the current low price-to-sales ratio of 0.6x.
moderate - The stock has shown a 1-year return of -14.8%, indicating some volatility.
